Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis B immune globulin: the US experience.

Clinical transplantation - 1 Jan 2000

Pruett T L, McGory R

Abstract excerpt

The increasingly aggressive use of hepatitis B immune globulin (HBIg) in liver transplantation for hepatitis B infected patients has led to a great improvement in this procedure by lowering the incidence of allograft infection. In this article, major US studies on the use of HBIg are reviewed, including clinical results, clinical failures and problems, and the remaining information still needed for optimal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Graft Survival
Share to Immunization, Passive
Share to Immunoglobulins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lamivudine

Share to Liver Transplantation

Share to Patient Selection

Share to Transplantation, Homologous

Share to Treatment Failure

Source

Identifiers

PMID: 10965958

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis B immune globulin: the US experience.PMID 10965958Read ↗

Prophylaxis and treatment of hepatitis B recurrence after liver transplantation in the antiviral era.Semantic proximity Read ↗

Management of hepatitis B virus infection in liver transplant recipients: prospects and challenges.Semantic proximity Read ↗

Preliminary results: outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotype.Semantic proximity Read ↗

Is hepatitis B immunoglobulin necessary in prophylaxis of hepatitis B recurrence after liver transplantation? A meta-analysis.Semantic proximity Read ↗

Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome.Semantic proximity Read ↗

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.Semantic proximity Read ↗

Management of hepatitis B after renal transplantation: an update.Semantic proximity Read ↗

Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation.Semantic proximity Read ↗

Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis.Semantic proximity Read ↗

[Liver transplantation for complications of hepatitis B].Semantic proximity Read ↗

Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.Semantic proximity Read ↗

Recurrent hepatitis C after liver transplantation: clinical and therapeutical issues.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.